Gewählte Publikation:
Sator, MO; Akramian, J; Joura, EA; Nessmann, A; Wedrich, A; Gruber, D; Metka, M; Huber, JC.
Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy.
MATURITAS 1998 29: 93-95.
Doi: 10.1016/S0378-5122(97)00091-1
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Wedrich Andreas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVES: To show the reducing effect of estrogens and progestins on the elevated intraocular pressure (IOP) in the case of a 56-year-old woman showing typical climacteric complaints, who was admitted to the menopause outpatient unit. She also suffered from a primary open-angle glaucoma treated with betaophtiole eye drops with intraocular pressures of 16-20 mmHg under this local therapy. METHODS: IOP patterns were monitored by means of standardised daily pressure profiles four times a day before as well as 4 and 12 weeks after the beginning of hormone replacement therapy (HRT). The local glaucoma therapy remained unchanged. RESULTS: During HRT, IOP levels were reduced from 16-20 mmHg before therapy to 12-15 mmHg at week 4 and to 13-15 mmHg at week 12 after the beginning of HRT. CONCLUSION: The finding of a close chronological relationship between the onset of menopause and the development of a glaucoma is a potentially new indication for HRT.
- Find related publications in this database (using NLM MeSH Indexing)
-
Antihypertensive Agents - therapeutic use
-
Drug Therapy, Combination - therapeutic use
-
Estradiol - therapeutic use
-
Estrogen Replacement Therapy - therapeutic use
-
Female - therapeutic use
-
Glaucoma - drug therapy
-
Humans - drug therapy
-
Intraocular Pressure - drug effects
-
Metipranolol - therapeutic use
-
Middle Aged - therapeutic use
-
Postmenopause - therapeutic use
-
Progesterone - therapeutic use
- Find related publications in this database (Keywords)
-
glaucoma
-
hormone replacement therapy
-
menopause